Read + Share
Amedeo Smart
Independent Medical Education
Yadav PD, Patil DY. Interim analysis of SARS-CoV-2 vaccine NVX-CoV2601 as a heterologous booster dose. Lancet Infect Dis 2025 Jan 14:S1473-3099(25)00005.PMID: 39824197
Email
LinkedIn
Privacy Policy